Involvement of neurosteroids in normal and pathological behaviour;Implicación de los neuroesteroides en la conducta normal y patológica

Revista de Neurologia

Volumn 44, Issue 11, 2007, Pages 661-676

  Martin Garcia E ^a   Darbra, S ^a   Pallarès, Marc ^a,b  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b Edificio B   (Spain)

Author keywords

Alcohol withdrawal syndrome; Alcoholism; Allopregnanolone; Anxiety disorders; Cognitive impairment; Epilepsy and convulsions; Learning and memory; Neurosteroids; Pregnenolone sulphate

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; NEUROSTEROID; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; ANTICONVULSIVE AGENT; STEROID;

ADDICTION; ALCOHOLISM; ANXIETY DISORDER; BEHAVIOR; BEHAVIOR DISORDER; COGNITION; COGNITIVE DEFECT; CONVULSION; DEGENERATIVE DISEASE; EPILEPSY; EPILEPTIC DISCHARGE; HORMONE SUBSTITUTION; HUMAN; MEDICAL RESEARCH; NERVOUS TISSUE; PATHOLOGY; PROTEIN FUNCTION; PSYCHOLOGY; REVIEW; RISK ASSESSMENT; SEDATION; SIDE EFFECT; ANIMAL; ANXIETY; CENTRAL NERVOUS SYSTEM; CHEMISTRY; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ALCOHOLISM; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANXIETY; BEHAVIOR; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITION DISORDERS; EPILEPSY; HUMANS; RECEPTORS, NEUROTRANSMITTER; STEROIDS;

EID: 35148818097     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4411.2006178     Document Type: Review

References (242)

1. Baulieu EE. Steroid hormones in the brain: several mechanisms? In Fuxe K, Gustafsson JA, Weterberg L, eds. Steroid hormone regulation of the brain. Oxford: Pergamon Press; 1981. p. 3-14.
2. Mayo W, George O, Darbra S, Bouyer JJ, Vallee M, Darnaudery M, et al. Individual differences in cognitive aging: implication of pregnenolone sulfate. Prog Neurobiol 2003; 71: 43-8.
3. Dubrovsky BO. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 169-92.
4. Paul SM, Purdy RH. Neuroactive steroids. FASEB J 1992; 6: 2311-22.
5. Baulieu EE. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998; 23: 963-87.
6. Corpechot C,Young J, Calvel M,Wehrey C, Veltz JN, Touyer G, et al. Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 1993; 133: 1003-9.
7. Tsutsui K, Ukena K, Usui M, Sakamoto H, Takase M. Novel brain function: biosynthesis and actions of neurosteroids in neurons. Neurosci Res 2000; 36: 261-73.
8. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr Rev 1993; 14: 222-40.
9. Papadopoulos V, Guarneri P, Kreuger KE, Guidotti A, Costa E. Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc Natl Acad Sci U S A 1992; 89: 5113-7.
10. Papadopoulos V, Brown AS. Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J Steroid Biochem Mol Biol 1995; 53:
11. Hall PF. The role of endozepine in the regulation of steroid synthesis. Mol Neurobiol 1995; 10: 1-17.
12. Papadopoulos V, Berkovich A, Krueger KE, Costa E, Guidotti A. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology 1991; 129: 1481-8.
13. Belelli D, Lambert JJ. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 2005; 6: 565-75.
14. Sierra A. Neurosteroids: the StAR protein in the brain. J Neuroendocrinol 2004; 16: 787-93.
15. Rupprecht R, Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 1999; 22: 410-6.
16. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 2003; 28: 139-68.
17. Akunne HC, Zoski KT, Whetzel SZ, Cordon JJ, Brandon RM, Roman F, et al. Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant. Neuropharmacology 2001; 41: 138-49.
18. Reddy DS, Kulkarni SK. The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology (Berl) 1998; 137: 391-400.
19. Reddy DS, Kaur G, Kulkarni SK. Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport 1998; 9: 3069-73.
20. Smith SS, Gong QH, Hsu FC, Markowitz RS, French-Mullen JM, Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998; 392: 926-30.
21. Smith SS. Withdrawal properties of a neuroactive steroid: implications for GABA(A) receptor gene regulation in the brain and anxiety behavior. Steroids 2002; 67: 519-28.
22. Wetzel CH, Hermann B, Behl C, Pestel E, Rammes G, Zieglgansberger W, et al. Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol 1998; 12: 1441-51.
23. Park-Chung M,Wu FS, Farb DH. 3 alpha-hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol Pharmacol 1994; 46: 146-50.
24. Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol 1991; 40: 333-6.
25. Valera S, Ballivet M, Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 1992; 89: 9949-53.
26. Harrison NL, Simmonds MA. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res 1984; 323: 287-92.
27. A receptor function. Trends Pharmacol Sci 1995; 16: 295-303.
28. Whiting PJ, McAllister G, Vassilatis D, Bonnert TP, Heavens RP, Smith DW, et al. Neuronally restricted RNA splicing regulates the expression of a novel GABAA receptor subunit conferring atypical functional properties. J Neurosci 1997; 17: 5027-37.
29. A receptor subunit composition? Receptors Channels 1993; 1: 135-42.
30. A receptors. Proc Natl Acad Sci U S A 2003; 100: 14439-44.
31. Belelli D, Pistis M, Peters JA, Lambert JJ. The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors. Neurochem Int 1999; 34: 447-52.
32. Lambert JJ, Belelli D, Harney SC, Peters JA, Frenguelli BG. Modulation of native and recombinant GABA(A) receptors by endogenous and synthetic neuroactive steroids. Brain Res Brain Res Rev 2001; 37: 68-80.
33. Gee KW. Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore. Mol Neurobiol 1988; 2: 291-317.
34. A receptor-mediated currents via a reduction of channel opening frequency. Brain Res 1989; 489: 190-94.
35. Akwa Y, Baulieu EE. Neurosteroids: behavioral aspects and physiological implications. J Soc Biol 1999; 193: 293-8.
36. A recognition site. Eur J Pharmacol 1996; 304: 141-6.
37. Williamson J, Mtchedlishvili Z, Kapur J. Characterization of the convulsant action of pregnenolone sulfate. Neuropharmacology 2004; 46: 856-64.
38. Darnaudery M, Pallarés M, Piazza PV, Le Moal M, Mayo W. The neurosteroid pregnenolone sulfate infused into the medial septum nucleus increases hippocampal acetylcholine and spatial memory in rats. Brain Res 2002; 951: 237-42.
39. Mayo W, Dellu F, Robel P, Cherkaoui J, Le Moal M, Baulieu EE, et al. Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res 1993; 607: 324-8.
40. Pallarés M, Darnaudery M, Day J, Le Moal M, Mayo W. The neurosteroid pregnenolone sulfate infused into the nucleus basalis increases both acetylcholine release in the frontal cortex or amygdala and spatial memory. Neuroscience 1998; 87: 551-8.
41. Melchior CL, Ritzmann RF. Pregnenolone and pregnenolone sulfate, alone and with ethanol, in mice on the plus-maze. Pharmacol Biochem Behav 1994; 48: 893-7.
42. Bowlby MR. Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol Pharmacol 1993; 43: 813-9.
43. Compagnone NA, Mellon SH. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci U S A 1998; 95: 4678-83.
44. Bergeron R, De Montigny C, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 1996; 16: 1193-202.
45. Mathis C, Vogel E, Cagniard B, Criscuolo F, Ungerer A. The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice. Neuropharmacology 1996; 35: 1057-64.
46. Mellon SH. Neurosteroids: biochemistry, modes of action, and clinical relevance. J Clin Endocrinol Metab 1994; 78: 1003-8.
47. Park-Chung M, Wu FS, Purdy RH, Malayev AA, Gibbs TT, Farb DH. Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids. Mol Pharmacol 1997; 52: 1113-23.
48. ++ responses: structure-activity studies. J Pharmacol Exp Ther 1994; 271: 677-82.
49. Lanthier A, Patwardhan VV. Sex steroids and 5-en-3 beta-hydroxysteroids in specific regions of the human brain and cranial nerves. J Steroid Biochem 1986; 25: 445-9.
50. Weill-Engerer S, David JP, Sazdovitch V, Liere P, Eychenne B, Pianos A, et al. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J Clin Endocrinol Metab 2002; 87: 5138-43.
51. Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A 1999; 96: 13512-7.
52. Morrow AL, VanDoren MJ, Penland SN, Matthews DB. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Brain Res Rev 2001; 37: 98-109.
53. Reddy DS, Kim HY, Rogawski MA. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 2001; 42: 328-36.
54. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 1996; 81: 3951-60.
55. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 1992; 75: 1002-4.
56. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002; 87: 5001-7.
57. Bernardi F, Salvestroni C, Casarosa E, Nappi RE, Lanzone A, Luisi S, et al. Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. Eur J Endocrinol 1998; 138: 316-21.
58. Mayo W, Le Moal M, Abrous DN. Pregnenolone sulfate and aging of cognitive functions: behavioral, neurochemical, and morphological investigations. Horm Behav 2001; 40: 215-7.
59. Sandi C. Implicacion de los glucocorticoides en la consolidacion de la memoria. Rev Neurol 2003; 37: 843-8.
60. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, García-Segura LM, et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 2003; 71: 3-29.
61. García-Segura LM, Veiga S, Sierra A, Melcangi RC, Azcoitia I. Aromatase: a neuroprotective enzyme. Prog Neurobiol 2003; 71: 31-41.
62. Veiga S, García-Segura LM, Azcoitia I. Propiedades neuroprotectoras de los esteroides sexuales y los neuroesteroides. Rev Neurol 2004; 39: 1043-51.
63. Flood JF, Morley JE, Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci U S A 1992; 89: 1567-71.
64. Flood JF, Morley JE, Roberts E. Pregnenolone sulfate enhances posttraining memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive. Proc Natl Acad Sci U S A 1995; 92: 10806-10.
65. Mathis C, Paul SM, Crawley JN. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task. Psychopharmacology 1994; 116: 201-6.
66. Vallee M, Mayo W, Darnaudery M, Corpechot C,Young J, Koehl M, et al. Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci U S A 1997; 94: 14865-70.
67. Martín-García E, Pallarés M. The neurosteroid pregnenolone sulfate neutralized the learning impairment induced by intrahippocampal nicotine in alcohol-drinking rats. Neuroscience 2005; 136: 1109-19.
68. Cheney DL, Uzunov D, Guidotti A. Pregnenolone sulfate antagonizes dizocilpine amnesia: role for allopregnanolone. Neuroreport 1995; 6: 1697-700.
69. Melchior CL, Ritzmann RF. Neurosteroids block the memory-impairing effects of ethanol in mice. Pharmacol Biochem Behav 1996; 53: 51-6.
70. Maurice T, Junien JL, Privat A. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors. Behav Brain Res 1997; 83: 159-64.
71. Urani A, Privat A, Maurice T. The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors. Brain Res 1998; 799: 64-77.
72. Isaacson RL, Varner JA, Baars JM, De Wied D. The effects of pregnenolone sulfate and ethylestrenol on retention of a passive avoidance task. Brain Res 1995; 689: 79-84.
73. Mtchedlishvili Z, Kapur J. A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission. Mol Pharmacol 2003; 64: 857-64.
74. Maren S, Holt WG. Hippocampus and Pavlovian fear conditioning in rats: muscimol infusions into the ventral, but not dorsal, hippocampus impair the acquisition of conditional freezing to an auditory conditional stimulus. Behav Neurosci 2004; 118: 97-110.
75. Ladurelle N, Eychenne B, Denton D, Blair-West J, Schumacher M, Robel P, et al. Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res 2000; 858: 371-9.
76. Frye CA, Sturgis JD. Neurosteroids affect spatial/reference, working, and long-term memory of female rats. Neurobiol Learn Mem 1995; 64: 83-96.
77. Dazzi L, Sanna A, Cagetti E, Concas A, Biggio G. Inhibition by the neurosteroid allopregnanolone of basal and stress-induced acetylcholine release in the brain of freely moving rats. Brain Res 1996; 710: 275-80.
78. Darnaudery M, Koehl M, Pallarés M, Le Moal M, Mayo W. The neurosteroid pregnenolone sulfate increases cortical acetylcholine release: a microdialysis study in freely moving rats. J Neurochem 1998; 71: 2018-22.
79. Meziane H, Mathis C, Paul SM, Ungerer A. The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task. Psychopharmacology 1996; 126: 323-30.
80. Johansson IM, Birzniece V, Lindblad C, Olsson T, Backstrom T. Allopregnanolone inhibits learning in the Morris water maze. Brain Res 2002; 934: 125-31.
81. Matthews DB, Morrow AL, Tokunaga S, McDaniel JR. Acute ethanol administration and acute allopregnanolone administration impair spatial memory in the Morris water task. Alcohol Clin Exp Res 2002; 26: 1747-51.
82. Dujardin K, Guerrien A, Leconte P. Sleep, brain activation and cognition. Physiol Behav 1990; 47: 1271-8.
83. Hennevin E, Hars B, Maho C, Bloch V. Processing of learned information in paradoxical sleep: relevance for memory. Behav Brain Res 1995; 69: 125-35.
84. Siegel JM. The REM sleep-memory consolidation hypothesis. Science 2001; 294: 1058-63.
85. Markowska AL, Stone WS, Ingram DK, Reynolds J, Gold PE, Conti LH, et al. Individual differences in aging: behavioral and neurobiological correlates. Neurobiol Aging 1989; 10: 31-43.
86. Chase MH, Morales FR. The atonia and myoclonia of active (REM) sleep. Annu Rev Psychol 1990; 41: 557-84.
87. Jones BE. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 1991; 40: 637-56.
88. Rye DB. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 1997; 20: 757-88.
89. Holsboer F, Grasser A, Friess E,Wiedemann K. Steroid effects on central neurons and implications for psychiatric and neurological disorders. Ann N Y Acad Sci 1994; 746: 345-59.
90. Xi MC, Morales FR, Chase MH. A GABAergic pontine reticular system is involved in the control of wakefulness and sleep. Sleep Res Online 1999; 2: 43-8.
91. Xi MC, Morales FR, Chase MH. Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism. J Neurophysiol 1999; 82: 2015-9.
92. Xi MC, Morales FR, Chase MH. The motor inhibitory system operating during active sleep is tonically suppressed by GABAergic mechanisms during other states. J Neurophysiol 2001; 86: 1908-15.
93. Xi MC, Morales FR, Chase MH. Interactions between GABAergic and cholinergic processes in the nucleus pontis oralis: neuronal mechanisms controlling active (rapid eye movement) sleep and wakefulness. J Neurosci 2004; 24: 10670-8.
94. Stone WS, Altman HJ, Berman RF, Caldwell DF, Kilbey MM. Association of sleep parameters and memory in intact old rats and young rats with lesions in the nucleus basalis magnocellularis. Behav Neurosci 1989; 103: 755-64.
95. Szymusiak R. Magnocellular nuclei of the basal forebrain: substrates of sleep and arousal regulation. Sleep 1995; 18: 478-500.
96. Darnaudery M, Pallarés M, Bouyer JJ, Le Moal M, Mayo W. Infusion of neurosteroids into the rat nucleus basalis affects paradoxical sleep in accordance with their memory modulating properties. Neuroscience 1999; 92: 583-8.
97. Darbra S, George O, Bouyer JJ, Piazza PV, Le Moal M, Mayo W. Sleep-wake states and cortical synchronization control by pregnenolone sulfate into the pedunculopontine nucleus. J Neurosci Res 2004; 76: 742-7.
98. Cardounel A, Regelson W, Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc Soc Exp Biol Med 1999; 222: 145-9.
99. Maurice T, Su TP, Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 1998; 83: 413-28.
100. Marczynski TJ. GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited. Brain Res Bull 1998; 45: 341-79.
101. Birkenhager-Gillesse EG, Derksen J, Lagaay AM. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Ann N Y Acad Sci 1994; 719: 543-52.
102. Nasman B, Olsson T, Backstrom T, Eriksson S, Grankvist K, Viitanen M, et al. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry 1991; 30: 684-90.
103. Morales AJ, Nolan JJ, Nelson JC,Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360-7.
104. Mesulam MM. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999; 24: 521-9.
105. Barnes CA. Aging and the physiology of spatial memory. Neurobiol Aging 1988; 9: 563-8.
106. Gould E, Tanapat P, Hastings NB, Shors TJ. Neurogenesis in adulthood: a possible role in learning. Trends Cogn Sci 1999; 3: 186-92.
107. Lemaire V, Koehl M, Le Moal M, Abrous DN. Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci U S A 2000; 97: 11032-7.
108. Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 1996; 16: 2027-33.
109. Haydar TF,Wang F, Schwartz ML, Rakic P. Differential modulation of proliferation in the neocortical ventricular and subventricular zones. J Neurosci 2000; 20: 5764-74.
110. LoTurco JJ, Owens DF, Heath MJ, Davis MB, Kriegstein AR. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 1995; 15: 1287-98.
111. Mayo W, Lemaire V, Malaterre J, Rodríguez JJ, Cayre M, Stewart MG, et al. Pregnenolone sulfate enhances neurogenesis and PSA-NCAM in young and aged hippocampus. Neurobiol Aging 2005; 26: 103-14.
112. Djebaili M, Hoffman SW, Stein DG. Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience 2004; 123: 349-59.
113. Djebaili M, Guo Q, Pettus EH, Hoffman SW, Stein DG. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 2005; 22: 106-18.
114. He J, Hoffman SW, Stein DG. Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor Neurol Neurosci 2004; 22: 19-31.
115. Akwa Y, Purdy RH, Koob GF, Britton KT. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 1999; 106: 119-25.
116. Zimmerberg B, McDonald BC. Prenatal alcohol exposure influences the effects of neuroactive steroids on separation-induced ultrasonic vocalizations in rat pups. Pharmacol Biochem Behav 1996; 55: 541-7.
117. Reddy DS, Kulkarni SK. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 1997; 752: 61-71.
118. A receptor function. Pharmacol Biochem Behav 1993; 45: 423-8.
119. Bitran D, Foley M, Audette D, Leslie N, Frye CA. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology 2000; 151: 64-71.
120. Crawley JN, Glowa JR, Majewska MD, Paul SM. Anxiolytic activity of an endogenous adrenal steroid. Brain Res 1986; 398: 382-5.
121. Patchev VK, Montkowski A, Rouskova D, Koranyi L, Holsboer F, Almeida OF. Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J Clin Invest 1997; 99: 962-6.
122. Picazo O, Fernández-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test. Brain Res 1995; 680: 135-41.
123. Vivian JA, Barros HM, Manitiu A, Miczek KA. Ultrasonic vocalizations in rat pups: modulation at the gamma-aminobutyric acid A receptor complex and the neurosteroid recognition site. J Pharmacol Exp Ther 1997; 282: 318-25.
124. Pick CG, Peter Y, Terkel J, Gavish M, Weizman R. Effect of the neuroactive steroid alpha-THDOC on staircase test behavior in mice. Psychopharmacology (Berl) 1996; 128: 61-6.
125. Pick CG, Peter Y, Paz L, Schreiber S, Gavish M,Weizman R. Effect of the pregnane-related GABA-active steroid alphaxalone on mice performance in the staircase test. Brain Res 1997; 765: 129-34.
126. Engel SR, Grant KA. Neurosteroids and behavior. Int Rev Neurobiol 2001; 46: 321-48.
127. Fernández-Guasti A, Picazo O. Flumazenil blocks the anxiolytic action of allopregnanolone. Eur J Pharmacol 1995; 281: 113-5.
128. Vanover KE, Suruki M, Robledo S, Huber M, Wieland S, Lan NC, et al. Positive allosteric modulators of the GABA(A) receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol. Psychopharmacology (Berl) 1999; 141: 77-82.
129. Patchev VK, Hassan AH, Holsboer DF, Almeida OF. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 1996; 15: 533-40.
130. File SE, Kenny PJ, Ouagazzal AM. Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav Neurosci 1998; 112: 1423-9.
131. Tucci SA, Genn RF, File SE. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors. Neuropharmacology 2003; 44: 367-73.
132. Martín-García E, Pallarés M. Intrahippocampal nicotine and neurosteroids effects on the anxiety-like behaviour in voluntary and chronic alcohol-drinking rats. Behav Brain Res 2005; 164: 117-27.
133. Finn DA, Roberts AJ, Lotrich F, Gallaher EJ. Genetic differences in behavioral sensitivity to a neuroactive steroid. J Pharmacol Exp Ther 1997; 280: 820-8.
134. Purdy RH, Morrow AL, Moore PH Jr, Paul SM. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci U S A 1991; 88: 4553-7.
135. A receptor function after acute stress. Neuroendocrinology 1996; 63: 166-72.
136. Melchior CL, Ritzmann RF. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav 1994; 47: 437-41.
137. Grobin AC, Matthews DB, Devaud LL, Morrow AL. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology 1998; 139: 2-19.
138. Silvers JM, Tokunaga S, Berry RB, White AM, Matthews DB. Impair ments in spatial learning and memory: ethanol, allopregnanolone, and the hippocampus. Brain Res Brain Res Rev 2003; 43: 275-84.
139. Frye GD, Chapin RE, Vogel RA, Mailman RB, Kilts CD, Mueller RA, et al. Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanol. J Pharmacol Exp Ther 1981; 216: 306-14.
140. LaBuda CJ, Fuchs PN. Catecholamine depletion by reserpine blocks the anxiolytic actions of ethanol in the rat. Alcohol 2002; 26: 55-9.
141. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 1975; 43: 245-54.
142. Givens B, McMahon K. Effects of ethanol on nonspatial working memory and attention in rats. Behav Neurosci 1997; 111: 275-82.
143. Matthews DB, Simson PE, Best PJ. Acute ethanol impairs spatial memory but not stimulus/response memory in the rat. Alcohol Clin Exp Res 1995; 19: 902-9.
144. Matthews DB, Ilgen M, White AM, Best PJ. Acute ethanol administration impairs spatial performance while facilitating nonspatial performance in rats. Neurobiol Learn Mem 1999; 72: 169-79.
145. Morrow AL, VanDoren MJ, Fleming R, Penland S. Ethanol and neurosteroid interactions in the brain. Int Rev Neurobiol 2001; 46: 349-77.
146. Koch-Weser J, Sellers EM, Kalant H. Alcohol intoxication and withdrawal. N Engl J Med 1976; 294: 757-62.
147. Belzung C, Berton F. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety. Behav Pharmacol 1997; 8: 541-8.
148. Bilkei-Gorzo A, Gyertyan I, Levay G. mCPP-induced anxiety in the light-dark box in rats -a new method for screening anxiolytic activity. Psychopharmacology 1998; 136: 291-8.
149. LaBuda CJ, Hale RL. Anxiety in mice following acute aspartame and ethanol exposure. Alcohol 2000; 20: 69-74.
150. Hirani K, Sharma AN, Jain NS, Ugale RR, Chopde CT. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology (Berl) 2005; 180: 267-78.
151. Barbaccia ML, Affricano D, Trabucchi M, Purdy RH, Colombo G, Agabio R, et al. Ethanol markedly increases 'GABAergic' neurosteroids in alcohol-preferring rats. Eur J Pharmacol 1999; 384: R1-2.
152. Finn DA, Ford MM, Wiren KM, Roselli CE, Crabbe JC. The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. Pharmacol Ther 2004; 101: 91-112.
153. VanDoren MJ, Matthews DB, Janis GC, Grobin AC, Devaud LL, Morrow AL. Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci 2000; 20: 1982-9.
154. Morrow AL, VanDoren MJ, Devaud LL. Effects of progesterone or neuroactive steroid? Nature 1998; 395: 652-3.
155. Bowen CA, Purdy RH, Grant KA. Ethanol-like discriminative stimulus effects of endogenous neuroactive steroids: effect of ethanol training dose and dosing procedure. J Pharmacol Exp Ther 1999; 289: 405-11.
156. Torres JM, Ortega E. Alcohol intoxication increases allopregnanolone levels in male adolescent humans. Psychopharmacology 2004; 172: 352-5.
157. Shope JT, Copeland LA, Dielman TE. Measurement of alcohol use and misuse in a cohort of students followed from grade 6 through grade 12. Alcohol Clin Exp Res 1994; 18: 726-33.
158. Janak PH, Redfern JE, Samson HH. The reinforcing effects of ethanol are altered by the endogenous neurosteroid, allopregnanolone. Alcohol Clin Exp Res 1998; 22: 1106-12.
159. Janis GC, Devaud LL, Mitsuyama H, Morrow AL. Effects of chronic ethanol consumption and withdrawal on the neuroactive steroid 3alpha-hydroxy-5alpha- pregnan-20-one in male and female rats. Alcohol Clin Exp Res 1998; 22: 2055-61.
160. Devaud LL, Purdy RH, Finn DA, Morrow AL. Sensitization of gamma-aminobutyric acid A receptors to neuroactive steroids in rats during ethanol withdrawal. J Pharmacol Exp Ther 1996; 278: 510-7.
161. Devaud LL, Fritschy JM, Sieghart W, Morrow AL. Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J Neurochem 1997; 69: 126-30.
162. Romeo E, Brancati A, De Lorenzo A, Fucci P, Furnari C, Pompili E, et al. Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clin Neuropharmacol 1996; 19: 366-9.
163. Finn DA, Gallaher EJ, Crabbe JC. Differential change in neuroactive steroid sensitivity during ethanol withdrawal. J Pharmacol Exp Ther 2000; 292: 394-405.
164. Martín-García E, Pallarés M. Effects of intrahippocampal nicotine and neurosteroids administration on withdrawal in voluntary and chronic alcohol-drinking rats. Alcohol Clin Exp Res 2005; 29: 1654-63.
165. Luntz-Leybman V, Freund RK, Collins AC. 5 alpha-Pregnan-3 alphaol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition. Eur J Pharmacol 1990; 185: 239-42.
166. Gasior M, Carter RB, Goldberg SR, Witkin JM. Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J Pharmacol Exp Ther 1997; 282: 543-53.
167. Kokate TG, Cohen AL, Karp E, Rogawski MA. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 1996; 35: 1049-56.
168. Frye CA. The neurosteroid 3 alpha, 5 apha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 1995; 696: 113-20.
169. Frye CA, Manjarrez J, Camacho-Arroyo I. Infusion of 3alpha,5alpha-THP to the pontine reticular formation attenuates PTZ-induced seizures. Brain Res 2000; 881: 98-102.
170. Martín-García E, Pallarés M. The intrahippocampal administration of the neurosteroid allopregnanolone blocks the audiogenic seizures induced by nicotine. Brain Res 2005; 1062: 144-50.
171. Frye CA, Bayon LE. Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha,5 alpha-THP. Neuroendocrinology 1998; 68: 272-80.
172. Reddy DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 2004; 62: 99-118.
173. Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999; 52: 1917-8.
174. Holmes GL, Weber DA. The effect of progesterone on kindling: a developmental study. Brain Res 1984; 318: 45-53.
175. Kokate TG, Banks MK, Magee T,Yamaguchi S, Rogawski MA. Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 1999; 288: 679-84.
176. Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 2003; 53: 390-1.
177. Belelli D, Casula A, Ling A, Lambert JJ. The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors. Neuropharmacology 2002; 43: 651-61.
178. Haigh JR, Feely M. Tolerance to the anticonvulsant effect of benzodiazepines. Trends Pharmacol Sci 1988; 9: 361-6.
179. Reddy DS, Rogawski MA. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 2001; 42: 337-44.
180. Monaghan EP, McAuley JW, Data JL. Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy. Expert Opin Invest Drugs 1999; 8: 1663-71.
181. Maione S, Berrino L,Vitagliano S, Leyva J, Rossi F. Pregnenolone sulfate increases the convulsant potency of N-methyl-D-aspartate in mice. Eur J Pharmacol 1992; 219: 477-9.
182. Reddy DS, Kulkarni SK. Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice. Eur J Pharmacol 1998; 345: 55-9.
183. Grobin AC, Heenan EJ, Lieberman JA, Morrow AL. Perinatal neurosteroid levels influence GABAergic interneuron localization in adult rat prefrontal cortex. J Neurosci 2003; 23: 1832-9.
184. King SR, Manna PR, Ishii T, Syapin PJ, Ginsberg SD,Wilson K, et al. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci 2002; 22: 10613-20.
185. Mameli M, Carta M, Partridge LD, Valenzuela CF. Neurosteroid-induced plasticity of immature synapses via retrograde modulation of presynaptic NMDA receptors. J Neurosci 2005; 25: 2285-94.
186. Grobin AC, Gizerian S, Lieberman JA, Morrow AL. Perinatal allopregnanolone influences prefrontal cortex structure, connectivity and behavior in adult rats. Neuroscience 2006; 138: 809-19.
187. Gizerian SS, Morrow AL, Lieberman JA, Grobin AC. Neonatal neurosteroid administration alters parvalbumin expression and neuron number in medial dorsal thalamus of adult rats. Brain Res 2004; 1012: 66-74.
188. Muneoka KT, Takigawa M. A neuroactive steroid, pregnenolone, alters the striatal dopaminergic tone before and after puberty. Neuroendocrinology 2002; 75: 288-95.
189. Muneoka KT, Borella A, Whitaker-Azmitia PM. Transient expression of S-100beta immunostaining in developing thalamus and somatosensory cortex of rat. Brain Res Dev Brain Res 2003; 142: 101-4.
190. Kilts CD. The changing roles and targets for animal models of schizophrenia. Biol Psychiatry 2001; 50: 845-55.
191. Shirayama Y, Muneoka KT, Iwata M, Ishida H, Hazama G, Kawahara R. Pregnenolone and dehydroepiandrosterone administration in neonatal rats alters the immunoreactivity of hippocampal synapsin I, neuropeptide Y and glial fibrillary acidic protein at post-puberty. Neuroscience 005; 133: 147-57.
192. A receptors during postnatal development. Neuroscience 2003; 118: 655-66.
193. Kudo K, Tachikawa E, Kashimoto T. Inhibition by pregnenolone sulfate of nicotinic acetylcholine response in adrenal chromaffin cells. Eur J Pharmacol 2002; 456: 19-27.
194. Bovenberg SA, Van Uum SH, Hermus AR. Dehydroepiandrosterone administration in humans: evidence based? Neth J Med 2005; 63: 300-4.
195. Reddy DS, Rogawski MA. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J Pharmacol Exp Ther 2000; 295: 1241-8.
196. Barrot M, Vallee M, Gingras MA, Le Moal M, Mayo W, Piazza PV. The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens. Eur J Neurosci 1999; 11: 3757-60.
197. Rouge-Pont F, Mayo W, Marinelli M, Gingras M, Le Moal M, Piazza PV. The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumens. Eur J Neurosci 2002; 16: 169-73.
198. Isaacson RL. Non-linear effects in the retention of an avoidance task induced by anabolic steroids. Eur J Pharmacol 2000; 405: 177-86.
199. Reddy DS, Kulkarni SK. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res 1998; 791: 108-16.
200. Reddy DS, Kulkarni SK. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res 1998; 799: 215-29.
201. Romeo E, Cheney DL, Zivkovic I, Costa E, Guidotti A. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone. J Pharmacol Exp Ther 1994; 270: 89-96.
202. Vallee M, Shen W, Heinrichs SC, Zorumski CF, Covey DF, Koob GF, et al. Steroid structure and pharmacological properties determine the anti-amnesic effects of pregnenolone sulphate in the passive avoidance task in rats. Eur J Neurosci 2001; 14: 2003-10.
203. Isaacson RL, Yoder PE, Varner J. The effects of pregnenolone on acquisition and retention of a food search task. Behav Neural Biol 1994; 61: 170-6.
204. Darnaudery M, Bouyer JJ, Pallarés M, Le Moal M, Mayo W. The promnesic neurosteroid pregnenolone sulfate increases paradoxical sleep in rats. Brain Res 1999; 818: 492-8.
205. Darnaudery M, Koehl M, Piazza PV, Le Moal M, Mayo W. Pregnenolone sulfate increases hippocampal acetylcholine release and spatial recognition. Brain Res 2000; 852: 173-9.
206. Akwa Y, Ladurelle N, Covey DF, Baulieu EE. The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms? Proc Natl Acad Sci U S A 2001; 98: 14033-7.
207. Li PK, Rhodes ME, Jagannathan S, Johnson DA. Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O- sulfamate. Brain Res Cogn Brain Res 1995; 2: 251-4.
208. Li PK, Rhodes ME, Burke AM, Johnson DA. Memory enhancement mediated by the steroid sulfatase inhibitor (p-O-sulfamoyl)-N-tetradecanoyl tyramine. Life Sci 1997; 60: L45-51.
209. Flood JF, Smith GE, Roberts E. Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 1988; 447: 269-78.
210. Migues PV, Johnston AN, Rose SP. Dehydroepiandosterone and its sulphate enhance memory retention in day-old chicks. Neuroscience 2002; 109: 243-51.
211. Fleshner M, Pugh CR, Tremblay D, Rudy JW. DHEA-S selectively impairs contextual-fear conditioning: support for the antiglucocorticoid hypothesis. Behav Neurosci 1997; 111: 512-7.
212. Flood JF, Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res 1988; 448: 178-81.
213. Roberts E, Bologa L, Flood JF, Smith GE. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res 1987; 406: 357-62.
214. Hoffman SW, Virmani S, Simkins RM, Stein DG. The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J Neurotrauma 2003; 20: 859-70.
215. Frye CA, Lacey EH. The neurosteroids DHEA and DHEAS may influence cognitive performance by altering affective state. Physiol Behav 1999; 66: 85-92.
216. Maurice T, Phan V, Sandillon F. Differential effect of dehydroepiandrosterone and its steroid precursor pregnenolone against the behavioural deficits in CO-exposed mice. Eur J Pharmacol 2000; 390: 145-55.
217. Fedotova J, Sapronov N. Behavioral effects of dehydroepiandrosterone in adult male rats. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1023-7.
218. Fedotova YO, Goncharov NP, Sapronov NS. Effect of dehydroepiandrosterone on avoidance behavior of adult male rats. Bull Exp Biol Med 2004; 138: 54-7.
219. Meunier J, Maurice T. Beneficial effects of the sigma1 receptor agonists igmesine and dehydroepiandrosterone against learning impairments in rats prenatally exposed to cocaine. Neurotoxicol Teratol 2004; 26: 783-97.
220. Shi J, Schulze S, Lardy HA. The effect of 7-oxo-DHEA acetate on memory in young and old C57BL/6 mice. Steroids 2000; 65: 124-9.
221. Turkmen S, Lundgren P, Birzniece V, Zingmark E, Backstrom T, Johansson IM. 3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone. Eur J Neurosci 2004; 20: 1604-12.
222. Turkmen S, Lofgren M, Birzniece V, Backstrom T, Johansson IM. Tolerance development to Morris water maze test impairments induced by acute allopregnanolone. Neuroscience 2006; 139: 651-9.
223. A modulators on complex behavior in rats. Psychopharmacology (Berl) 2004; 173: 195-202.
224. Chesler EJ, Juraska JM. Acute administration of estrogen and progesterone impairs the acquisition of the spatial Morris water maze in ovariectomized rats. Horm Behav 2000; 38: 234-42.
225. Gibson CL, Murphy SP. Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J Cereb Blood Flow Metab 2004; 24: 805-13.
226. Goss CW, Hoffman SW, Stein DG. Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol Biochem Behav 2003;76: 231-42.
227. Vongher JM, Frye CA. Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacol Biochem Behav 1999; 64: 777-85.
228. Roof RL, Duvdevani R, Braswell L, Stein DG. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 1994; 129: 64-9.
229. Reddy DS, Kulkarni SK. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice. Methods Find Exp Clin Pharmacol 1997; 19: 665-81.
230. Jorge JC, González L, Fortis A, Cruz ND. Sex-specific modulation of anxiety and locomotion after neonatal exposure to pregnenolone sulfate. Physiol Behav 2005; 83: 779-86.
231. Jain NS, Hirani K, Chopde CT. Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats. Neuropharmacology 2005; 48: 627-38.
232. Wieland S, Belluzzi JD, Stein L, Lan NC. Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents. Psychopharmacology (Berl) 1995; 118: 65-71.
233. A receptor. Brain Res 1991; 561: 157-61.
234. Reddy DS, O'Malley BW, Rogawski MA. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 2005; 48: 14-24.
235. Bitran D, Dugan M, Renda P, Ellis R, Foley M. Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res 1999; 850: 217-24.
236. Brot MD, Akwa Y, Purdy RH, Koob GF, Britton KT. The anxiolyticlike effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur J Pharmacol 1997; 325: 1-7.
237. Zimmerberg B, Brunelli SA, Hofer MA. Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone. Pharmacol Biochem Behav 1994; 47: 735-8.
238. Zimmerberg B, Kajunski EW. Sexually dimorphic effects of postnatal allopregnanolone on the development of anxiety behavior after early deprivation. Pharmacol Biochem Behav 2004; 78: 465-71.
239. Bitran D, Klibansky DA, Martin GA. The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat. Psychopharmacology (Berl) 2000; 151: 31-7.
240. Molina-Hernández M, Téllez-Alcántara NP, Pérez GJ, Olivera-López JI, Teresa JM. Anti-conflict-like actions of intralateral septal infusions of allopregnanolone in Wistar rats. Pharmacol Biochem Behav 2003; 75: 397-404.
241. Reddy DS, Kulkarni SK. Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology (Berl) 1996; 128: 280-92.
242. A receptors. J Neuroendocrinol 1995; 7: 171-7.